These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 38332401)

  • 41. Human platelet alloantigens (HPA) 1, HPA2, HPA3, HPA4, and HPA5 polymorphisms in sickle cell anemia patients with vaso-occlusive crisis.
    Al-Subaie AM; Fawaz NA; Mahdi N; Al-Absi IK; Al-Ola K; Ameen G; Almawi WY
    Eur J Haematol; 2009 Dec; 83(6):579-85. PubMed ID: 19702628
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Sickle cell disease clinical phenotypes in children from South-Western, Nigeria.
    Adegoke SA; Adeodu OO; Adekile AD
    Niger J Clin Pract; 2015; 18(1):95-101. PubMed ID: 25511352
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Relevance of fibrinolytic protein (D-dimer) and fibrinopeptide A as markers of sickle cell anaemia vaso-occlusive crisis.
    Ekwere TA; Ebele U; Ekanem M; Ogunro PS
    Niger Postgrad Med J; 2014 Sep; 21(3):225-30. PubMed ID: 25331238
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Plasma concentration of fucosyltransferase 7 is not associated with the number of clinically overt vaso-occlusive events in sickle cell disease.
    Okpala IE; Eze OE; Ezekekwu CA; Nnakenyi ID; Ilechukwu GU; Akpa CO; Nwani EI; Maduka CJ; Anigbogu IO; Muoghalu ED; Ugwu NI; Ajuba IC; Aneke JC; Okoye HC; Nonyelu CC; Duru AN
    Ghana Med J; 2023 Sep; 57(3):198-203. PubMed ID: 38957672
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Changes in Blood Profile from Steady State in Patients with Sickle Cell Anemia Admitted for Vaso-occlusive Crisis and Acute Chest Syndrome.
    Klouda T; Raybagkar D; Bernstein B; Apollonsky N
    Adv Hematol; 2020; 2020():3656717. PubMed ID: 32908517
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Whole blood transcriptomic analysis reveals PLSCR4 as a potential marker for vaso-occlusive crises in sickle cell disease.
    Abdulwahab H; Aljishi M; Sultan A; Al-Kafaji G; Sridharan K; Bakhiet M; Taha S
    Sci Rep; 2021 Nov; 11(1):22199. PubMed ID: 34772994
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Plasma histamine elevation in a large cohort of sickle cell disease patients.
    Allali S; Lionnet F; Mattioni S; Callebert J; Stankovic Stojanovic K; Bachmeyer C; Arlet JB; Brousse V; de Montalembert M; Chalumeau M; Grateau G; Maciel TT; Launay JM; Hermine O; Georgin-Lavialle S
    Br J Haematol; 2019 Jul; 186(1):125-129. PubMed ID: 30924132
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Phospholipase A2 levels in acute chest syndrome of sickle cell disease.
    Styles LA; Schalkwijk CG; Aarsman AJ; Vichinsky EP; Lubin BH; Kuypers FA
    Blood; 1996 Mar; 87(6):2573-8. PubMed ID: 8630425
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Lipid and hemolysis parameters predicting acute chest syndrome in adulthood with sickle cell disease.
    Feugray G; Grall M; Dumesnil C; Brunel V; Benhamou Y; Quillard Muraine M; Billoir P
    Lipids Health Dis; 2024 May; 23(1):140. PubMed ID: 38755670
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Serum IL-6, IL-10, and TNFα levels in pediatric sickle cell disease patients during vasoocclusive crisis and steady state condition.
    Sarray S; Saleh LR; Lisa Saldanha F; Al-Habboubi HH; Mahdi N; Almawi WY
    Cytokine; 2015 Mar; 72(1):43-7. PubMed ID: 25569375
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Comparative study of hypercoagulability change in steady state and during vaso-occlusive crisis among Sudanese patients living with sickle cell disease.
    Mohamed EA; Elgari MM; Babker AM; Waggiallah HA
    Afr Health Sci; 2020 Mar; 20(1):392-396. PubMed ID: 33402927
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Exacerbation of oxidative stress during sickle vaso-occlusive crisis is associated with decreased anti-band 3 autoantibodies rate and increased red blood cell-derived microparticle level: a prospective study.
    Hierso R; Lemonne N; Villaescusa R; Lalanne-Mistrih ML; Charlot K; Etienne-Julan M; Tressières B; Lamarre Y; Tarer V; Garnier Y; Hernandez AA; Ferracci S; Connes P; Romana M; Hardy-Dessources MD
    Br J Haematol; 2017 Mar; 176(5):805-813. PubMed ID: 27984639
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Sickle cell acute chest syndrome: pathogenesis and rationale for treatment.
    Stuart MJ; Setty BN
    Blood; 1999 Sep; 94(5):1555-60. PubMed ID: 10477680
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Acute chest syndrome: sickle cell disease.
    Paul RN; Castro OL; Aggarwal A; Oneal PA
    Eur J Haematol; 2011 Sep; 87(3):191-207. PubMed ID: 21615795
    [TBL] [Abstract][Full Text] [Related]  

  • 55. ADAMTS13 and von Willebrand factor assessment in steady state and acute vaso-occlusive crisis of sickle cell disease.
    Demagny J; Driss A; Stepanian A; Anguel N; Affo L; Roux D; Habibi A; Benghezal S; Capdenat S; Coppo P; Driss F; Veyradier A
    Res Pract Thromb Haemost; 2021 Jan; 5(1):197-203. PubMed ID: 33537544
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Protein Z polymorphisms associated with vaso-occlusive crisis in young sickle cell disease patients.
    Mahdi N; Abu-Hijleh TM; Abu-Hijleh FM; Sater MS; Al-Ola K; Almawi WY
    Ann Hematol; 2012 Aug; 91(8):1215-20. PubMed ID: 22576309
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Is morphine exposure associated with acute chest syndrome in children with vaso-occlusive crisis of sickle cell disease? A 6-year case-crossover study.
    Finkelstein Y; Schechter T; Garcia-Bournissen F; Kirby M; Nurmohamed L; Juurlink DN; Blanchette V; Koren G
    Clin Ther; 2007 Dec; 29(12):2738-43. PubMed ID: 18201591
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Shear-Stress-Gradient and Oxygen-Gradient Ektacytometry in Sickle Cell Patients at Steady State and during Vaso-Occlusive Crises.
    Boisson C; Nader E; Renoux C; Gauthier A; Poutrel S; Bertrand Y; Stauffer E; Virot E; Hot A; Fort R; Cannas G; Joly P; Connes P
    Cells; 2022 Feb; 11(3):. PubMed ID: 35159394
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Evaluation of reticulated platelets in patients with sickle cell diseases.
    Noronha JF; Costa FF; Saad ST; Lorand-Metze IG; Grotto HZ
    Thromb Res; 2007; 121(2):259-67. PubMed ID: 17521711
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Assessment of Reticulocyte and Erythrocyte Parameters From Automated Blood Counts in Vaso-Occlusive Crisis on Sickle Cell Disease.
    Feugray G; Kasonga F; Grall M; Benhamou Y; Bobée-Schneider V; Buchonnet G; Daliphard S; Le Cam Duchez V; Lahary A; Billoir P
    Front Med (Lausanne); 2022; 9():858911. PubMed ID: 35492334
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.